X4 Pharmaceuticals Inc (XFOR) Stock Analysis

X4 Pharmaceuticals Inc (XFOR) is a publicly traded company in the HEALTHCARE sector. It trades at $4.04, carries a market capitalization of $387.65M. This page summarizes the public market data, fundamentals, and frequently asked questions for XFOR, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $4.04
• Market Cap: $387.65M
• EPS: $-2.07
• 52-Week High: $4.83
• 52-Week Low: $1.35

Market Sentiment

X4 Pharmaceuticals Inc currently has a Bullish sentiment score of 0.39.

About X4 Pharmaceuticals Inc

X4 Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm based in Boston, Massachusetts, focused on developing innovative therapies for rare and serious diseases, particularly in the realm of back disorders. The company employs its proprietary biology to create cutting-edge treatments aimed at enhancing patient outcomes. With a robust pipeline of investigational therapies progressing through various clinical development phases, X4 is strategically positioned to address significant ...

GNG Research Analysis

GNG Research scores X4 Pharmaceuticals Inc (XFOR) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for XFOR.

Frequently Asked Questions

Does XFOR pay dividends?

X4 Pharmaceuticals Inc (XFOR) does not currently pay a regular dividend.

What is XFOR's market cap?

X4 Pharmaceuticals Inc (XFOR) has a market capitalization of $387.65M with a current stock price of $4.04.